BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8137276)

  • 21. Inhibition of NMU-induced mammary tumorigenesis by dietary soy.
    Simmen RC; Eason RR; Till SR; Chatman L; Velarde MC; Geng Y; Korourian S; Badger TM
    Cancer Lett; 2005 Jun; 224(1):45-52. PubMed ID: 15911100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
    Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
    Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic analogs of vitamin D3 have inhibitory effects on breast cancer cell lines.
    Fioravanti L; Miodini P; Cappelletti V; DiFronzo G
    Anticancer Res; 1998; 18(3A):1703-8. PubMed ID: 9673393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LAS, a novel selective estrogen receptor modulator with chemopreventive and therapeutic activity in the N-nitroso-N-methylurea-induced rat mammary tumor model.
    Cohen LA; Pittman B; Wang CX; Aliaga C; Yu L; Moyer JD
    Cancer Res; 2001 Dec; 61(24):8683-8. PubMed ID: 11751385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3 and 1alpha,25-dihydroxy-16-ene-23-yne-20-epi-vitamin D3: analogs of 1alpha,25-dihydroxyvitamin D3 that resist metabolism through the C-24 oxidation pathway are metabolized through the C-3 epimerization pathway.
    Reddy GS; Rao DS; Siu-Caldera ML; Astecker N; Weiskopf A; Vouros P; Sasso GJ; Manchand PS; Uskokovic MR
    Arch Biochem Biophys; 2000 Nov; 383(2):197-205. PubMed ID: 11185554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low zinc intake suppressed N-methyl-N-nitrosourea-induced mammary tumorigenesis in Sprague-Dawley rats.
    Lee S; Simpson M; Nimmo M; Xu Z
    Carcinogenesis; 2004 Oct; 25(10):1879-85. PubMed ID: 15205360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.
    Guo Y; Mazar AP; Lebrun JJ; Rabbani SA
    Cancer Res; 2002 Aug; 62(16):4678-84. PubMed ID: 12183425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of melatonin and tamoxifen as a chemoprophylaxis against N-nitroso-N-methylurea-induced rat mammary tumors.
    Kothari A; Borges A; Ingle A; Kothari L
    Cancer Lett; 1997 Jan; 111(1-2):59-66. PubMed ID: 9022128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stage-specific inhibition of mammary carcinogenesis by 1alpha-hydroxyvitamin D5.
    Mehta RG
    Eur J Cancer; 2004 Oct; 40(15):2331-7. PubMed ID: 15454260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of methylnitrosourea-induced breast cancer in Sprague Dawley rats by dehydroepiandrosterone: dose-dependent inhibition, effects of limited exposure, effects on peroxisomal enzymes, and lack of effects on levels of Ha-Ras mutations.
    Lubet RA; Gordon GB; Prough RA; Lei XD; You M; Wang Y; Grubbs CJ; Steele VE; Kelloff GJ; Thomas CF; Moon RD
    Cancer Res; 1998 Mar; 58(5):921-6. PubMed ID: 9500451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nimesulide and melatonin in mammary carcinogenesis prevention in female Sprague-Dawley rats.
    Kubatka P; Kalická K; Chamilová M; Ahlersová E; Ahlers I; Bojková B; Adámeková E
    Neoplasma; 2002; 49(4):255-9. PubMed ID: 12382025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diets containing whey proteins or soy protein isolate protect against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in female rats.
    Hakkak R; Korourian S; Shelnutt SR; Lensing S; Ronis MJ; Badger TM
    Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):113-7. PubMed ID: 10667471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma.
    Bischoff ED; Gottardis MM; Moon TE; Heyman RA; Lamph WW
    Cancer Res; 1998 Feb; 58(3):479-84. PubMed ID: 9458093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, suppresses the growth of carcinogen-induced mammary tumors.
    Cohen LA; Marks PA; Rifkind RA; Amin S; Desai D; Pittman B; Richon VM
    Anticancer Res; 2002; 22(3):1497-504. PubMed ID: 12168829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of retinyl acetate and melatonin on N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats. A preliminary report.
    Bojková B; Kubatka P; Môciková K; Mníchová M; Ahlersová E; Ahlers I
    Folia Biol (Praha); 2000; 46(2):73-6. PubMed ID: 10813094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of fish oil on the chemopreventive efficacy of tamoxifen against development of N-methyl-N-nitrosourea-induced rat mammary carcinogenesis.
    Manni A; Xu H; Washington S; Aliaga C; Cooper T; Richie JP; Bruggeman R; Prokopczyk B; Calcagnotto A; Trushin N; Mauger D; Verderame MF; El-Bayoumy K
    Cancer Prev Res (Phila); 2010 Mar; 3(3):322-30. PubMed ID: 20179301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of N-methyl-N-nitrosourea-induced breast cancer by alpha-fetoprotein (AFP)-derived peptide, a peptide derived from the active site of AFP.
    Parikh RR; Gildener-Leapman N; Narendran A; Lin HY; Lemanski N; Bennett JA; Jacobson HI; Andersen TT
    Clin Cancer Res; 2005 Dec; 11(23):8512-20. PubMed ID: 16322315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of growth inhibition of mammary carcinomas by glucarate and the glucarate: retinoid combination.
    Webb TE; Abou-Issa H; Stromberg PC; Curley RC; Nguyen MH
    Anticancer Res; 1993; 13(6A):2095-9. PubMed ID: 8297119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term modulation of cell proliferation and apoptosis and preventive/therapeutic efficacy of various agents in a mammary cancer model.
    Christov K; Grubbs CJ; Shilkaitis A; Juliana MM; Lubet RA
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5488-96. PubMed ID: 17875779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gemini vitamin D analogues inhibit estrogen receptor-positive and estrogen receptor-negative mammary tumorigenesis without hypercalcemic toxicity.
    Lee HJ; Paul S; Atalla N; Thomas PE; Lin X; Yang I; Buckley B; Lu G; Zheng X; Lou YR; Conney AH; Maehr H; Adorini L; Uskokovic M; Suh N
    Cancer Prev Res (Phila); 2008 Nov; 1(6):476-84. PubMed ID: 19138995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.